Aujourd'hui Bulles Univers Watchlists Portefeuilles ETF Corrélation Playbook Articles Recherche Alertes Actualités Bots À propos

Bulletin quotidien

Un email par jour · alertes + rotations de bulles · gratuit en bêta.

À propos Articles Alertes Recherche Soutenir ♡Mentions légales Conditions Confidentialité API Suivre sur X

Actions US · Clôture quotidienne · Mis à jour chaque nuit à 22h30 Paris

Not investment advice. QuantAbundancia is educational research only. Nothing on this site is a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Full disclosures.

We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.

Actualités

Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

4,364 signal articles · 55 in last 24h · 19,203 total before filter · latest 1h ago

55last 24h

1680last 7d

312🟢 bullish (7d)

171🔴 bearish (7d)

136publishers

ticker: ABTsentiment: bullishSentiment:

Barchart1d agobullish

3 Dividend Aristocrats Under $100 to Buy and Hold Forever

These three Dividend Aristocrats under $100 offer steady payouts, reasonable payout ratios, and analyst-backed upside potential.

Motley Fool5d agobullish

3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow

How does a rising 3.4% dividend and a growing portfolio of drugs sound?

Zacks5d ago

bullish

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

ABT